Skip to main navigation
Skip to search
Skip to main content
PolyU Scholars Hub Home
Help & FAQ
Link opens in a new tab
Search content at PolyU Scholars Hub
Home
Researchers
Units
Research output
Prizes
Activities
Press/Media
Student theses
Gold-doxorubicin nanoconjugates for overcoming multidrug resistance
Yan Juan Gu
, Jinping Cheng
, Cornelia Wing Yin Man
,
Wing Tak Wong
, Shuk Han Cheng
The Hong Kong Polytechnic University
Department of Applied Biology and Chemical Technology
Research output
:
Journal article publication
›
Journal article
›
Academic research
›
peer-review
165
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Gold-doxorubicin nanoconjugates for overcoming multidrug resistance'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Doxorubicin
100%
Multidrug Resistance
100%
Nanoconjugates
100%
Cancer Chemotherapy
37%
Au Nanoparticles (AuNPs)
37%
Multidrug Resistance Reversal
25%
Multidrug Resistance in Cancer
25%
Cytotoxicity
12%
Anticancer Drugs
12%
Cancer Cells
12%
Mass Spectrometry Analysis
12%
Inductively Coupled Plasma Mass Spectrometry
12%
Gold Nanoparticles
12%
Confocal Image
12%
Cytotoxicity Test
12%
Intracellular Uptake
12%
Drug Accumulation
12%
PEGylated
12%
Gold Nanoparticles(AuNPs)
12%
Cleavable
12%
Disulfide Linkage
12%
Nanoparticle Dose
12%
Multidrug Resistance Cancer
12%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Multidrug Resistance
100%
Nanoconjugate
100%
Polyethylene Glycol
50%
Cancer Chemotherapy
37%
Gold Nanoparticle
25%
Cytotoxicity
25%
Disulfide
12%
Malignant Neoplasm
12%
Anticarcinogen
12%
Nanoparticle
12%
Inductively Coupled Plasma
12%
Chemistry
Multiple Drug Resistance
100%
Doxorubicin
100%
Nanoconjugate
100%
Poly(ethylene Glycol)
50%
Gold Nanoparticle
25%
Inductively Coupled Plasm Mass Spectrometry (ICPMS)
12%
Disulfide
12%
Nanoparticle
12%
Material Science
Gold Nanoparticles
100%
Polyethylene Glycol
100%
Gold Nanoparticles
50%
Nanoparticle
25%
Immunology and Microbiology
Multidrug Resistance
100%
Cytotoxicity
25%
Blood Plasma
12%
Cancer Cell
12%
Drug Accumulation
12%